# A Study Evaluating Nexagon™ in the Treatment of Skin Wounds.

> **NCT00736593** · PHASE1 · COMPLETED · sponsor: **OcuNexus Therapeutics, Inc.** · enrollment: 43 (estimated)

## Conditions studied

- Wound Healing

## Interventions

- **DRUG:** Nexagon™ or Nexagon™ vehicle

## Key facts

- **NCT ID:** NCT00736593
- **Lead sponsor:** OcuNexus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-04
- **Target enrollment:** 43 (ESTIMATED)
- **Last updated:** 2009-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00736593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00736593, "A Study Evaluating Nexagon™ in the Treatment of Skin Wounds.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00736593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*